Sort
326,823 grants matching “clinical trial”
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
$2,220,754David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2013 · HL
Mental Health Research Network III
$2,220,745Gregory E Simon · Kaiser Foundation Research Institute · U19 · FY2019 · MH
SPORE in Lung Cancer
$2,220,687Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2006 · CA
Development of New Antitumor Agents
$2,220,631Southern Research Institute · P01 · FY2004 · CA
Lymphoma Specialized Program of Research Excellence
$2,220,335George J Weiner · University Of Iowa · P50 · FY2006 · CA
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,220,216Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2018 · AI
Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium
$2,220,049Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2024 · DK
Center of Excellence in Diabetes and Obesity Research
$2,220,000Aruni Bhatnagar Bhatnagar · University Of Louisville · P20 · FY2010 · RR
DAIT CLINICAL SITE MONITORING CENTER
$2,220,000Mary Glessner · Ppd Development Lp · N01 · FY2014 · AI
HEPATITIS C CLINICAL TRIAL-DATA COORDINATING CENTER
$2,219,985Anna Slavin · · N01 · FY2007 · DK
Development/production of H5 influenza DNA plasmid vaccine
$2,219,937Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Telomere Diseases
$2,219,794Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,219,794Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
$2,219,762James Douglas Engel · University Of Michigan At Ann Arbor · P01 · FY2019 · HL
Multidisciplinary Clinical Research Programs (RMI)
$2,219,681University Of Pittsburgh At Pittsburgh · K12 · FY2005 · RR
Targeting the Tumor Vasculature to Treat Cancer
$2,219,678Steven K. Libutti · Clinical Sciences · Z01 · FY2007 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,219,566Barbara Burtness · Yale University · P50 · FY2022 · DE
Studies of Childhood Solid Tumors
$2,219,539Peter J Houghton · St. Jude Children'S Research Hospital · P01 · FY2008 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$2,219,279Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Diverse Strategies to Correct the Dystrophin Gene Using Vascular Delivery (U54)
$2,219,184Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2007 · NS
Novel Small Molecule Inhibitors of Botulinum Neurotoxin A
$2,219,077Terry L Bowlin · Microbiotix, Inc · U01 · FY2009 · AI
Topiramate as a Disease Altering Therapy for CSPN
$2,219,043A Gordon Smith · Virginia Commonwealth University · U01 · FY2018 · NS
Neurobiological Phenotyping Core
$2,218,999Richard E Harris · University Of Michigan At Ann Arbor · U19 · FY2019 · AR
ECOG-ACRIN Biorepositories to Support NCTN
$2,218,340Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2018 · CA
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,218,284John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA